Regulatory Updates
🇪🇺 EMA Page 10EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 109–120 of 171 articles
EMA's CHMP Endorses Four New Medicines: May Meeting Insights
EU Draft Deal Addresses Essential Medicine Shortages
EMA and FDA Align on Good AI Practice in Drug Development
May 2026 Global Health & WASH Funding Opportunities
SERD Therapy Shows Strong Anti-Proliferative Activity in ER+/HER2- Breast Cancer
FDA Advances Real-Time Clinical Trials Implementation
US Raises Concerns Over EU Pharmaceutical Regulations
Why Europe Must Boost Clinical Trials for Future Growth
The Critical Medicines Act: Transforming Pharma Manufacturing in Europe
MaaT Pharma Q1 2026 Business Update and Financial Results
ESMO Breast Cancer Congress 2026: Key Insights for Investors
Ireland's Clinical Trials: A Comparative Analysis with EU Peers